Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Change in Accured Expenses (2016 - 2025)

Cytokinetics (CYTK) has disclosed Change in Accured Expenses for 16 consecutive years, with $29.5 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses changed N/A to $29.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $33.6 million for FY2025, 136.94% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $29.5 million at Cytokinetics, up from -$14.4 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $32.1 million in Q4 2023, with the low at -$14.4 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $3.7 million, with a median of $4.2 million recorded in 2023.
  • Peak annual rise in Change in Accured Expenses hit 9253.56% in 2023, while the deepest fall reached 287.96% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $1.2 million in 2021, then tumbled by 128.33% to -$351000.0 in 2022, then soared by 9253.56% to $32.1 million in 2023, then tumbled by 82.85% to $5.5 million in 2024, then surged by 435.26% to $29.5 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $29.5 million, -$14.4 million, and $5.5 million for Q4 2025, Q1 2025, and Q3 2024 respectively.